Although JAK2 is phosphorylated in cytokine-independent BCR-ABL-positive CML cells, aberrant JAK/STAT signaling has been implicated in various tumors [14]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.